NEOGENOMICS INC — Director's Dealing 2014

Mar 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2014-02-07

Reporting Person: JONES STEVEN C (Director, Executive VP of Finance)
Reporting Person: ASPEN SELECT HEALTHCARE LP (Director, Executive VP of Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-07	Common Stock	A	83333	$0.75	Acquired	212745	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-07	Warrants (Right to Buy)	$0.75	A	83333	Acquired	2014-02-09	Common Stock (0)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3500000	Indirect
Common Stock	50476	Indirect
Common Stock	34857	Indirect
Common Stock	190000	Indirect
Common Stock	346615	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants (Right to Buy)	$1.5	2017-05-03	Common Stock (0)	450000	Direct

Footnotes

F1: Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: An investment partnershsip entity controlled by Steven Jones. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his pecuniary interests therein.

F3: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010.